Demonstration of a Rational Strategy for Human Prostate Cancer Gene Therapy-Reference-Cited by-同舟云学术

Demonstration of a Rational Strategy for Human Prostate Cancer Gene Therapy

Published:1994-03 Issue:3 Volume:151 Page:622-628
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Sanda Martin G.¹²³,Ayyagari Sujatha R.¹²³,Jaffee Elizabeth M.¹²³,Epstein Jonathan I.¹²³,Clift Shirley L.¹²³,Cohen Lawrence K.¹²³,Dranoff Glenn¹²³,Pardoll Drew M.¹²³,Mulligan Richard C.¹²³,Simons Jonathan W.¹²³

Affiliation:

1. From the Brady Urological Institute, Johns Hopkins Oncology Center and Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland

2. Somatix Therapy Corporation, Alameda, California

3. Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference38 articles.

1. Cancer statistics, 1993;Boring;CA,1993

2. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate;Stamey;New Engl. J. Med.,1987

3. The value of serum prostate specific antigen deteriminations before and after radical prostatectomy;Lange;J. Urol.,1989

4. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer;Catalona;New Engl. J. Med.,1991

5. Carcinoma of the prostate;Gittes;New Engl. J. Med.,1991

Cited by 205 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccines;Seminars in Cancer Biology;2023-01

2. Cancer Vaccines: Promising Therapeutics or an Unattainable Dream;Vaccines;2021-06-18

3. Immuno-oncology: a narrative review of gastrointestinal and hepatic toxicities;Annals of Translational Medicine;2021-03

4. Breakthrough concepts in immune‐oncology: Cancer vaccines at the bedside;Journal of Leukocyte Biology;2020-06-18

5. Leptin promotes proliferation and inhibits apoptosis of prostate cancer cells by regulating ERK1/2 signaling pathway;EUR REV MED PHARMACO;2020